VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
RPRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
RPRXRoyalty Pharma plc
$58.44$25.9B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksRPRXQuarterly Financials

Royalty Pharma plc (RPRX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Royalty Pharma plc (RPRX) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

RPRX Income Statement

Quarterly statement

RPRX Income Statement

Royalty Pharma plc (RPRX) annual income statement — 9-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue674.14M630.58M621.99M609.29M578.66M568.25M593.64M564.69M537.27M567.98M596.07M536.31M538.2M683.97M565.75M573.46M535.96M562.05M575.7M585.77M
Revenue Growth %16.5%10.97%4.78%7.9%7.71%0.05%-0.41%5.29%-0.17%-16.96%5.36%-6.48%0.42%21.69%-1.73%-2.1%-3.43%-1.92%0.62%8.8%
Cost of Goods Sold268.22M1.17M000000000000000000
COGS % of Revenue39.79%0.19%------------------
Gross Profit405.93M629.4M621.99M609.29M578.66M568.25M593.64M564.69M537.27M567.98M596.07M536.31M538.2M683.97M565.75M573.46M535.96M562.05M575.7M585.77M
Gross Margin %60.21%99.81%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %-29.85%10.76%4.78%7.9%7.71%0.05%-0.41%5.29%-0.17%-16.96%5.36%-6.48%0.42%21.69%-1.73%-2.1%-3.43%-1.92%0.62%8.8%
Operating Expenses272.81M-3.08M233.61M182.13M368.87M34.06M232.13M-170.38M267.64M641.75M-16.83M384.87M289.36M205M1.05B381.25M158.16M342.33M422.28M282.72M
OpEx % of Revenue40.47%-0.49%37.56%29.89%63.74%5.99%39.1%-30.17%49.81%112.99%-2.82%71.76%53.76%29.97%185.31%66.48%29.51%60.91%73.35%48.26%
Selling, General & Admin161.89M159M164.27M118.73M179.77M110.7M67.59M56.72M54.71M57.65M59.19M57.23M47.63M85.69M73.23M50.69M51.84M51.54M46.16M48.59M
SG&A % of Revenue24.01%25.21%26.41%19.49%31.07%19.48%11.39%10.04%10.18%10.15%9.93%10.67%8.85%12.53%12.94%8.84%9.67%9.17%8.02%8.29%
Research & Development97.85M40M51M50.5M300.5M50.5M500K500K500K500K500K50.5M500K500K50.5M25.5M606K100.5M103.82M90.5M
R&D % of Revenue14.51%6.34%8.2%8.29%51.93%8.89%0.08%0.09%0.09%0.09%0.08%9.42%0.09%0.07%8.93%4.45%0.11%17.88%18.03%15.45%
Other Operating Expenses1000K-1000K1000K1000K-1000K-1000K1000K-1000K1000K1000K-1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income133M632.48M388.38M427.16M209.8M534.18M361.51M735.07M269.63M-73.77M612.9M151.44M248.84M478.97M-482.65M192.21M377.79M219.72M153.42M303.05M
Operating Margin %19.73%100.3%62.44%70.11%36.26%94.01%60.9%130.17%50.19%-12.99%102.82%28.24%46.24%70.03%-85.31%33.52%70.49%39.09%26.65%51.74%
Operating Income Growth %-36.61%18.4%7.43%-41.89%-22.19%824.08%-41.02%385.38%8.35%-115.4%226.98%-21.21%-34.13%117.99%-414.6%-36.58%-49.29%-4.18%-51.15%-40.64%
EBITDA175.1M633.65M389.58M428.43M159.3M498.69M400.11M872.86M243.39M39.96M764.84M168.11M398.29M556.04M-563.08M267.39M538.56M225.39M159.21M308.85M
EBITDA Margin %25.97%100.49%62.63%70.32%27.53%87.76%67.4%154.57%45.3%7.04%128.31%31.35%74%81.3%-99.53%46.63%100.49%40.1%27.66%52.72%
EBITDA Growth %9.92%27.06%-2.63%-50.92%-34.55%1148.01%-47.69%419.22%-38.89%-92.81%235.83%-37.13%-26.05%146.7%-453.66%-13.42%-28.26%-4.08%-50.22%-40.19%
D&A (Non-Cash Add-back)01.17M1.2M1.28M00000000000005.67M5.8M5.8M
EBIT175.1M561.98M450.08M523.77M159.3M498.69M400.11M872.86M243.39M39.96M764.84M168.11M398.29M556.04M-563.08M267.39M538.56M175.15M100.64M266.12M
Net Interest Income-88.49M-87.49M-87.1M-72.66M-60.34M-53.97M-56.72M-49M-35.63M-36.81M-40.76M-22.6M-21.3M-30.25M-3.1M-32.94M-36.05M-37.53M-36.34M-32.07M
Interest Income5.13M6.23M7.07M6.9M8.33M11.29M9.04M17.51M13.38M7.42M6.5M23.44M25.65M16.7M43.85M14.03M10.92M9.53M10.64M12.26M
Interest Expense93.62M93.72M94.17M79.56M68.67M65.26M65.76M66.51M49.01M44.23M47.26M46.03M46.95M46.95M46.95M46.98M46.97M47.06M46.97M44.33M
Other Income/Expense-51.63M-164.22M-32.47M17.05M-119.16M-100.75M-27.16M71.28M-75.25M69.5M104.69M-29.36M102.5M30.12M-127.38M28.2M113.81M-91.64M-99.75M-81.26M
Pretax Income81.49M468.26M355.91M444.21M90.64M433.43M334.35M806.36M194.38M-4.27M717.59M122.08M351.34M509.09M-610.03M220.41M491.6M128.08M53.67M221.8M
Pretax Margin %12.09%74.26%57.22%72.91%15.66%76.28%56.32%142.8%36.18%-0.75%120.39%22.76%65.28%74.43%-107.83%38.44%91.72%22.79%9.32%37.86%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income17.88M295M214.21M288.22M30.18M238.35M208.21M543.99M102M4.78M494.34M72.11M227.63M340.75M-456.08M142.65M304.5M51.76M7.9M101.93M
Net Margin %2.65%46.78%34.44%47.3%5.21%41.94%35.07%96.33%18.99%0.84%82.93%13.45%42.29%49.82%-80.62%24.88%56.82%9.21%1.37%17.4%
Net Income Growth %-40.74%23.77%2.88%-47.02%-70.42%4888.47%-57.88%654.34%-55.19%-98.6%208.39%-49.45%-25.25%558.32%-5870.29%39.95%-30.92%-25.11%-95.38%-64.93%
Net Income (Continuing)81.49M468.26M355.91M444.21M90.64M433.43M334.35M806.36M194.38M-4.27M717.59M122.08M351.34M509.09M-610.03M220.41M491.6M128.08M53.67M221.8M
Discontinued Operations00000000000000000000
Minority Interest91.28M3.05B3.24B3.21B3.16B3.1B3.4B3.39B3.28B3.36B3.56B3.45B3.53B3.87B3.9B4.26B4.38B4.36B4.47B4.59B
EPS (Diluted)0.040.530.500.670.070.410.471.210.230.011.100.160.500.76-1.240.320.700.120.020.24
EPS Growth %-42.86%29.27%6.38%-44.63%-69.57%4000%-57.27%656.25%-54%-98.68%188.71%-50%-28.57%533.33%-8100%33.33%-35.19%-33.33%101.94%-69.62%
EPS (Basic)0.040.680.641.050.090.550.471.220.230.011.480.210.510.76-1.470.450.970.120.020.34
Diluted Shares Outstanding556.9M559.61M559.61M559.61M562.3M578.1M589M593M596.91M597.48M602.02M601.14M605.86M607.25M522.61M607.23M607.21M607.2M510.99M607.17M
Basic Shares Outstanding445.06M431.89M431.89M431.89M423.51M435.48M445.99M446.04M451.02M448.62M448.02M448.44M450.4M445.61M441.79M439.29M436.32M433.96M421.51M428.23M
Dividend Payout Ratio1170.98%35.42%44.04%33.07%308.99%40.01%44.98%17.29%93.08%1963.27%18.07%124.46%39.8%26.01%-58.75%27.27%158.93%931.21%71.64%